Changes to the website
Sponsored By
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma (ACT IV)
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 26 to 50 of about 4386

Previous 25           Next 25
Website Changes
03/27/2014 The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
03/27/2014 Musella Foundation is pleased to receive a $1,000 grant from The Allstate Foundation
03/27/2014 Inhibitory Effect of Disulfiram/Copper Complex on Non-small Cell Lung Cancer Cells.
03/24/2014 The Amazon Smile Foundation will donate an extra $5 to the Musella Foundation for each shopper!
03/24/2014 Changes to the Musella Foundation Website: "Clinical Trials And Noteworthy Treatments For Brain Tumors"
03/22/2014 FDA agrees to let patients get controversial drug
03/22/2014 Added a new page on vaccines and immunotherapies. There is a nice chart that shows all of the vaccines avaialable!
03/22/2014 New article on vaccines and immunotherapies
03/21/2014 Vulnerability of Glioblastoma Cells to Catastrophic Vacuolization and Death Induced by a Small Molecule
03/19/2014 Methods for the detection of cytomegalovirus in glioblastoma cells and tissues.
03/19/2014 IBM’s Watson, New York Genome Center partner on brain cancer treatment
03/18/2014 First Patient Enrolled in GenSpera G-202 Phase II Glioblastoma Trial
03/18/2014 Hoops for Hannah college basketball contest.
03/16/2014 Doctors decode chemo resistance in childhood brain tumour, find potential drug
03/13/2014 Small But Fierce: Four Funders Come Together for Brain Tumor Research
03/13/2014 IBTA E-NEWS
03/13/2014 Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacy
03/12/2014 http://phys.org/wire-news/156012592/aacr-recognizes-contributions-of-multi-institutional-research-te.html
03/12/2014 Musella Foundation Copay Assist program is now closed!
03/11/2014 Exclusive: Germany OKs Northwest Bio brain cancer drug, shares soar
03/11/2014 Tocagen Doses First Patient Intravenously in Clinical Trial of Selective Cancer Therapy, Toca 511 & Toca FC
03/08/2014 Researchers at the University of California, San Diego School of Medicine have discovered that FDA-approved anti-psychotic drugs possess tumor-killing activity against the most aggressive form of primary brain cancer, glioblastoma.
03/08/2014 Implications of bevacizumab (Avastin) discontinuation in adults with recurrent glioblastoma.
03/07/2014 NW Bio Receives Recommendation To Continue With Phase III GBM Brain Cancer Trial Based On Data Safety Monitoring Board`s Safety Review
03/06/2014 Cellectar begins phase II imaging trial of I-124-CLR1404 in patients with glioblastoma



Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure NovoTTF-100A | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us | Doctors Address Book



Copyright (c) 1993 - 2014 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites